speb/financial-data huggingface dataset:
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 383806000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Total Debt: 22033000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 383806000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Total Expenses: 114940000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 151231000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 146966000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 27486000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 54135000.00
MEDI.OL income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 896000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 64243.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Work In Process: 375000.00
MEDI.OL balance_sheet (quarterly, 2025-06-30) — Working Capital: 264327000.00
MEDI.OL income_statement (annual, 2025-12-31) — +Operating Expense: 375396000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — +Operating Expense: 103840000.00
MEDI.OL income_statement (annual, 2025-12-31) — +Total Revenue: 699767000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — +Total Revenue: 182295000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Accounts Payable: 26629000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 26629000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 86388000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 86388000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -175586000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -175586000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 72736000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 72736000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1501000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1501000.00
MEDI.OL income_statement (annual, 2025-12-31) — Basic Average Shares: 18276358.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Basic Average Shares: 18276358.00
MEDI.OL income_statement (annual, 2025-12-31) — Basic EPS: 8.71
MEDI.OL income_statement (quarterly, 2025-12-31) — Basic EPS: 2.08
MEDI.OL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 179210000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 157663000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Capital Expenditure: -33010000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 49271000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 49271000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Capital Stock: 4584000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4584000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 206188000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 206188000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 206188000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 206188000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -109465000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Cash Financial: 206188000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Cash Financial: 206188000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -1542000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Change In Inventory: -612000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Change In Payable: 8899000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Change In Receivables: -17408000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Change In Working Capital: -10663000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 2444000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Changes In Cash: 30598000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Changes In Cash: 54426000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Common Stock: 4584000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Common Stock: 4584000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -109465000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 468406000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 468406000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 8159000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Common Stock Payments: -4654000.00
MEDI.OL income_statement (annual, 2025-12-31) — Cost Of Revenue: 128174000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 36130000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Current Assets: 477721000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Current Assets: 477721000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 11594000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 11594000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 11594000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 11594000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Current Liabilities: 143209000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 143209000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Current Provisions: 6192000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Current Provisions: 6192000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Depreciation: 16015000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Depreciation: -1792000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 16015000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: -1792000.00
MEDI.OL income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 24828000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 7022000.00
MEDI.OL income_statement (annual, 2025-12-31) — Depreciation Income Statement: 24828000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 7022000.00
MEDI.OL income_statement (annual, 2025-12-31) — Diluted Average Shares: 18276358.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 18276358.00
MEDI.OL income_statement (annual, 2025-12-31) — Diluted EPS: 8.71
MEDI.OL income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.08
MEDI.OL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 159210000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 38088000.00
MEDI.OL income_statement (annual, 2025-12-31) — EBIT: 213079000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — EBIT: 42325000.00
MEDI.OL income_statement (annual, 2025-12-31) — EBITDA: 237907000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — EBITDA: 49347000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 2280000.00
MEDI.OL cash_flow (annual, 2025-12-31) — End Cash Position: 212088000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — End Cash Position: 212088000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Financing Cash Flow: -123476000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 5940000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Finished Goods: 84476000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Finished Goods: 84476000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Free Cash Flow: 154074000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 66009000.00
MEDI.OL income_statement (annual, 2025-12-31) — General And Administrative Expense: 47589000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Goodwill: 14128000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Goodwill: 14128000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 86098000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 86098000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 87889000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 87889000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Gross PPE: 254971000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 254971000.00
MEDI.OL income_statement (annual, 2025-12-31) — Gross Profit: 571593000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Gross Profit: 146165000.00
MEDI.OL income_statement (annual, 2025-12-31) — Interest Expense: 6230000.00
MEDI.OL income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 6230000.00
MEDI.OL income_statement (annual, 2025-12-31) — Interest Income: 5006000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Interest Income: 1910000.00
MEDI.OL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 5006000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1910000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Interest Received Cfo: 3223000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -15468000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -15468000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Inventory: 161132000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Inventory: 161132000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Invested Capital: 468406000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 468406000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Investing Cash Flow: -33010000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -17523000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 8159000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 37677000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 37677000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 37677000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 37677000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -4654000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 8159000.00
MEDI.OL income_statement (annual, 2025-12-31) — Net Income: 159210000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Net Income: 38088000.00
MEDI.OL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 159210000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 38088000.00
MEDI.OL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 159210000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 38088000.00
MEDI.OL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 159210000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 38088000.00
MEDI.OL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 159210000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 38088000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 206849000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 47845000.00
MEDI.OL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 159210000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 38088000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -17484000.00
MEDI.OL income_statement (annual, 2025-12-31) — Net Interest Income: 246000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Net Interest Income: -1024000.00
MEDI.OL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 246000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1024000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Net PPE: 79385000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Net PPE: 79385000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -15526000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 382308000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 382308000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 11309000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 11309000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 9221000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 9221000.00
MEDI.OL income_statement (annual, 2025-12-31) — Normalized EBITDA: 237907000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 49347000.00
MEDI.OL income_statement (annual, 2025-12-31) — Normalized Income: 159210000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Normalized Income: 38088000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Operating Cash Flow: 187084000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 66009000.00
MEDI.OL income_statement (annual, 2025-12-31) — Operating Income: 196197000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Operating Income: 42325000.00
MEDI.OL income_statement (annual, 2025-12-31) — Operating Revenue: 699767000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Operating Revenue: 182295000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 18282848.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 18282848.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Other Current Assets: 1000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 5990000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 5990000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Other Equity Interest: 419649000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 419649000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 71970000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 71970000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Other Inventories: 11412000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Other Inventories: 11412000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1000.00
MEDI.OL income_statement (annual, 2025-12-31) — Other Operating Expenses: 80249000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 33322000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Other Properties: 254971000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Other Properties: 254971000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Other Receivables: 6941000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Other Receivables: 6941000.00
MEDI.OL income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Payables: 78884000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Payables: 78884000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11106000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11106000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Prepaid Assets: 7484000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 7484000.00
MEDI.OL income_statement (annual, 2025-12-31) — Pretax Income: 206849000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Pretax Income: 47845000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -17484000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Purchase Of PPE: -15526000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Raw Materials: 75124000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Raw Materials: 75124000.00
MEDI.OL income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 128174000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 36130000.00
MEDI.OL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 16015000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: -1792000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -4654000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Restricted Cash: 5900000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 5900000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Retained Earnings: 368817000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 368817000.00
MEDI.OL income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 14772000.00
MEDI.OL income_statement (annual, 2025-12-31) — Selling General And Administration: 62361000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Share Issued: 18337336.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Share Issued: 18337336.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 468406000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 468406000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Tangible Book Value: 382308000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 382308000.00
MEDI.OL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
MEDI.OL income_statement (annual, 2025-12-31) — Tax Provision: 47639000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Tax Provision: 9757000.00
MEDI.OL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.23
MEDI.OL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
MEDI.OL balance_sheet (annual, 2025-12-31) — Taxes Receivable: 3687000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 3687000.00
MEDI.OL cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -28340000.00
MEDI.OL cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: 0.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Total Assets: 660601000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Total Assets: 660601000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Total Capitalization: 468406000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 468406000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Total Debt: 49271000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Total Debt: 49271000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 468406000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 468406000.00
MEDI.OL income_statement (annual, 2025-12-31) — Total Expenses: 503570000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Total Expenses: 139970000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 192195000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 192195000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 182881000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 182881000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 48986000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 48986000.00
MEDI.OL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 196196000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 42325000.00
MEDI.OL income_statement (annual, 2025-12-31) — Total Other Finance Cost: -1470000.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 2934000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Total Tax Payable: 52255000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 52255000.00
MEDI.OL income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
MEDI.OL income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDI.OL income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 54488.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 54488.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Treasury Stock: 14000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 14000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Work In Process: 5588000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Work In Process: 5588000.00
MEDI.OL balance_sheet (annual, 2025-12-31) — Working Capital: 334512000.00
MEDI.OL balance_sheet (quarterly, 2025-12-31) — Working Capital: 334512000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — +Operating Expense: 103351000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — +Total Revenue: 201666000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 104466000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 44172000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 18289000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Basic EPS: 2.20
MEDI.OL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 212088000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 34595000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4585000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 209785000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 209785000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -15997000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2303000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Common Stock: 4585000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: 0.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 506744000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 41226000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Current Assets: 492081000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 129641000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Depreciation: 3319000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3319000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 6219000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 6219000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 18289000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.20
MEDI.OL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 40295000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — EBIT: 51920000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — EBITDA: 58139000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — End Cash Position: 209784000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -2900000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Finished Goods: 70769000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 7223000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Goodwill: 14128000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 101702000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Gross Profit: 160440000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Interest Expense: 398000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 398000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Interest Income: 895000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 895000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -14984000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Inventory: 160386000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 506744000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -6626000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 34595000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 34595000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Net Income: 40295000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 40295000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 40295000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 40295000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 40295000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 51522000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 40295000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Net Interest Income: 807000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 807000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Net PPE: 88103000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 405042000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 10904000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 58139000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Normalized Income: 40295000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 7223000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Operating Income: 57089000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Operating Revenue: 201666000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 18282848.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Other Current Assets: -1000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 457987000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 87574000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Other Inventories: 11610000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -1000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 38049000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Other Receivables: 17445000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Pretax Income: 51522000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Raw Materials: 87484000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 41226000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3319000.00
MEDI.OL cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Share Issued: 18337336.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 506744000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 405042000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Tax Provision: 11227000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
MEDI.OL cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -14141000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Total Assets: 681885000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 506744000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Total Debt: 34595000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 506744000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Total Expenses: 144577000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 175141000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 189804000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 45500000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 57089000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -310000.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
MEDI.OL income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 54488.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Work In Process: 5507000.00
MEDI.OL balance_sheet (quarterly, 2026-03-31) — Working Capital: 362440000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -804400000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 745860000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -215870000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Amortization: 75400000.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 75400000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 700900000.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -172150000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 145950000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 780000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 0.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 0.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of Business: -69700000.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 9370000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 230310000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 1403570000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Interest Income: 31290000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 31290000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 499670000.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: -57670000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 112210000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 45640000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Other Payable: 132940000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 187140000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Other Special Charges: -86440000.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 0.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 46440000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 346230000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: -57670000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 16290000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 16290000.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: 0.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 30410000.00
MEDIASSIST.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 2260550000.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 90270000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 72620000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 302930000.00
MEDIASSIST.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: 0.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 790000.00
MEDIASSIST.NS income_statement (annual, 2022-03-31) — Write Off: 105710000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — +Operating Expense: 3466500000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — +Total Revenue: 5023750000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 364280000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1271570000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -846690000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 745860000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -156120000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Amortization: 67720000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 67720000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 56810000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 68859212.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Basic EPS: 10.76
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 145950000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 894230000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -276690000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 306020000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 344300000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 539440000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1706470000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -130140000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 26000000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 513440000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -101750000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 47530000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Change In Payable: -52610000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 36660000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -51470000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 390660000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Common Stock: 344300000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -130140000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3766110000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 24590000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 611050000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Current Assets: 4421350000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 119120000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Current Debt: 770000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 119890000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 430000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2785360000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 56050000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Depreciation: 199970000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 267690000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 267690000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 199970000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 73360000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 68859212.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Diluted EPS: 10.76
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 740590000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — EBIT: 1065340000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — EBITDA: 1333030000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 2830000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — End Cash Position: 539440000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -315250000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 534100000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -60200000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: -12560000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 4760000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 299850000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Goodwill: 754310000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1172010000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1427690000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 1414180000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Gross Profit: 4412700000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Interest Expense: 29250000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 29250000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Interest Income: 41680000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 41680000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -2100000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 35410000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 3766880000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -104880000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 56810000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 186900000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 186900000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 478100000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 70610000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Minority Interests: 170000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -275690000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 1970000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Income: 740590000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 740590000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 753080000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: -12660000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 740590000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 753250000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1019170000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 740420000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: 0.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Interest Income: 11790000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 412090000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -42830000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 11790000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Net PPE: 567490000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -276690000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -42830000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2594100000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 91300000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 32480000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 142340000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 743130000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1255960000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Normalized Income: 697231820.50
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 810790000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Operating Income: 946200000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Operating Revenue: 5023750000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 68859212.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 115740000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 413360000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 417700000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -21120000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -10000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 3000000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 739360000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Other Payable: 209430000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Other Properties: 17260000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 251320000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1167030000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Other Special Charges: -5570000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Payables: 574140000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 0.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 64890000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 342140000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Pretax Income: 1036090000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 19900000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -275690000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: 0.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1107010000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -276690000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 611050000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 267690000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 12530000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 12530000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -42830000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 849850000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2748150000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 1540490000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 185580000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 485430000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Share Issued: 68859212.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -42830000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Special Income Charges: 4310000.00
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 32790000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3766110000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2594100000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 21051820.50
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Tax Provision: 283010000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.27
MEDIASSIST.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -391400000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Total Assets: 7057160000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 3766110000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Total Debt: 306790000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 3836720000.00
MEDIASSIST.NS income_statement (annual, 2023-03-31) — Total Expenses: 4077550000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3220440000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2635810000.00
MEDIASSIST.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 435080000.00